Solid Start to 2025: USANA Revenue Growth Q1
USANA has kicked off the year strong, reporting net sales of $250 million in the first quarter of 2025—up from $228 million in Q1 2024. This marks a 10% year-over-year growth, or 12% in constant currency, highlighting robust demand across its global markets.
According to Jim Brown, President and CEO of USANA:
“USANA is off to a solid start to the year as we continue to execute our growth strategy through our core direct sales business and our recently acquired direct-to-consumer business, Hiya. We are seeing encouraging signs in our direct sales business with net sales and Active Customers growing modestly on a sequential basis for the second consecutive quarter.”
The company’s acquisition of Hiya is proving successful, showing impressive gains in both net sales and monthly subscribers. Hiya’s growth trajectory remains positive, with several new product launches and strategic partnerships in the pipeline for 2025.
“Hiya’s momentum remains strong and should continue building as their team executes their plans… We continue to be confident in the growth trajectory of this business that is reaching a new customer demographic for us,” Brown added.
Despite macroeconomic uncertainties—like global trade volatility and shifting consumer sentiment—USANA’s core business has remained steady. Their manufacturing hubs in the U.S. and China offer operational advantages, ensuring seamless supply chain performance.
“Our supply chain team has actively managed our inventory levels and sourcing and will continue to work with our stakeholders in each of our markets to navigate the increasingly dynamic operating environment,” Brown stated.
USANA Health Sciences is a global leader in the development and manufacture of high-quality nutritional supplements, personal care items, and functional foods. It operates across over 25 countries, serving a diverse and growing customer base.
USANA also holds a 78.8% controlling stake in Hiya Health Products, a leading children’s wellness brand offering clean-label health solutions.
Learn more at: www.usana.com and www.hiyahealth.com.
For investors and industry watchers, the USANA Revenue Growth Q1 update reflects confidence, diversification, and sustainable long-term planning in a shifting global market.
Usana’s revenue dropped by 7% in 2024.
Discover the key reasons behind the decline in our in-depth Usana report here.
There are no reviews yet. Be the first one to write one.
